Finance

Lists
Why is XLO down 2,41%?
Dive Deeper
XLO:NASDAQ
Xilio Therapeutics Inc
8,50 $
-2,41%
(-0,21) 1D
5 նոյ, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XLO...
Open
8,45 $
High
8,65 $
Low
7,78 $
Mkt. cap
55,93 մլն
Avg. vol.
13,45 հզր
Volume
26,92 հզր
52-wk high
11,90 $
52-wk low
6,47 $
EPS
-1,54 $
Beta
-0,11
Shares outstanding
6,58 մլն
No. of employees
76
Open
8,45 $
High
8,65 $
Low
7,78 $
Mkt. cap
55,93 մլն
Avg. vol.
13,45 հզր
Volume
26,92 հզր
52-wk high
11,90 $
52-wk low
6,47 $
EPS
-1,54 $
Beta
-0,11
Shares outstanding
6,58 մլն
No. of employees
76
News stories
From web sources and news partners
About Xilio Therapeutics Inc
CEO-
Employees76
Founded2016
HeadquartersՈւոլթեմ, Մասսաչուսեթս, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Analyst
Recommendation
Action
Price target
Projected
Date
Marc Frahm
TD Cowen
Buy
Maintained
-
-
11/13/2025
Next call 7 օրից
նոյ 12, հնգ, 16:30
Fiscal period
Q3 2026
- / -1,68 $
Revenue / Est. (USD)
- / 4,92 մլն
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
19,07 մլն
13,69 մլն
12,65 մլն
18,69 մլն
Cost of goods sold
14,32 մլն
-37,92 մլն
19,83 մլն
14,56 մլն
Cost of revenue
14,32 մլն
-37,92 մլն
19,83 մլն
14,56 մլն
Research and development expenses
-
56,04 մլն
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,67 մլն
7,40 մլն
6,93 մլն
7,62 մլն
Operating expense
6,67 մլն
63,44 մլն
6,93 մլն
7,62 մլն
Total operating expenses
21,00 մլն
25,52 մլն
26,76 մլն
22,18 մլն
Operating income
-1,93 մլն
-11,84 մլն
-14,11 մլն
-3,49 մլն
Other non operating income
-14,36 մլն
24,70 մլն
3,30 մլն
-2,88 մլն
EBT including unusual items
-16,29 մլն
10,36 մլն
-9,53 մլն
-6,37 մլն
EBT excluding unusual items
-16,29 մլն
10,36 մլն
-9,53 մլն
-6,37 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16,29 մլն
10,36 մլն
-9,53 մլն
-6,37 մլն
Net profit margin
-85,42%
75,70%
-75,34%
-34,09%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,28 մլն
-
Interest expense
-
-2,50 մլն
-
-
Net interest expenses
-
-2,50 մլն
1,28 մլն
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,59 մլն
-11,51 մլն
-13,77 մլն
-3,16 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps